CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Nissui Pharmaceutical Co., Ltd. Company Snapshot
Nissui Pharmaceutical Co., Ltd. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nissui Pharmaceutical Co., Ltd. with three other pharmaceutical manufacturers in Asia: Searle Co Ltd of PAKISTAN (2020 sales of 20.47 billion Pakistan Rupees [US$127.35 million] ), Caplin Point Laboratories Limited of INDIA (8.63 billion Indian Rupees [US$116.36 million] of which 100% was Pharmaceuticals formulations), and Shilpa Medicare Limited which is also based in INDIA (9.08 billion Indian Rupees [US$122.39 million] of which 98% was Pharmaceutical products and services).

Sales Analysis. During the year ended March of 2020, sales at Nissui Pharmaceutical Co., Ltd. were ¥12.77 billion (US$122.49 million). This is a very small increase of 1.8% versus 2019, when the company's sales were ¥12.55 billion. The sales level in 2020 was fairly close to the level five years ago: in 2015, Nissui Pharmaceutical Co., Ltd. had sales of ¥11.86 billion. Sales of Diagnostics saw an increase of 2.3% in 2020, from ¥10.08 billion to ¥10.31 billion. Not all segments of Nissui Pharmaceutical Co., Ltd. experienced an increase in sales in 2020: sales of Pharmaceuticals fell 0.5% to ¥2.46 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Nissui Pharmaceutical Co., Ltd.
  Stock Performance Chart for Nissui Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 1,085.00
(Figures in Japanese Yen )
1 Week -2.0%   13 Weeks -6.3%  
4 Weeks -1.4%   52 Weeks -17.6%  
 
Nissui Pharmaceutical Co., Ltd. Key Data:
  Ticker: 4550 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2020 Sales 12,773,000,000
(Year Ending Jan 2021).
Employees: 306
  Currency: Japanese Yen Market Cap: 24,297,942,445
  Fiscal Yr Ends: March Shares Outstanding: 22,394,407
  Share Type: Common Closely Held Shares: 12,987,664
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.